Open AccessA Randomized clinical trial on Ardhavabhedaka– Migraine and its Ayurvedic management
Author(s) -
DB Vaghela,
Shweta Mata,
Kartar Singh Dhiman,
Manjusha Rajagopala
Publication year - 2016
Publication title -
international journal of ayurvedic medicine
Language(s) - English
Resource type - Journals
ISSN - 0976-5921
DOI - 10.47552/ijam.v7i1.721
Subject(s) - medicine , migraine , placebo , group b , placebo group , group a , adverse effect , clinical trial , alternative medicine , traditional medicine , pathology
Ardhavabhedaka defines Ardha Mastak Vedana. The word migraine is derived from the Greek word hemicranias, meaning "half of the head". Migraine is now recognized as a chronic illness, not simply a headache. Many medications have been tried and a lot are still in research work also, but modern drugs are not acceptable due to their drawbacks. In contrast to that Ayurveda has a variety of natural medication in the treatment of Ardhavabhedaka. It was planned to compare the result between Laghu Sutashekhara Rasa orally in Group A, Brihat Dashamoola Taila Nasya in Group B, placebo drug in Group C and Go-ghrita Nasya in Group D. The overall effect of therapy showed that in Group A 38% patients cured and 36% patients got marked improvement. In Group B 46.67% patients moderately improved and 35.55% patients marked improved. In Group C 90% patients unchanged. In Group D 48.89% patients moderately improved and 28.89% patients marked improved. No any adverse drug reaction was found during whole study. Total 150 patients were registered and from the results and observation which were received from this study it can be concluded that Group A is showing better results in Ardhavabhedaka.Â